PECULIARITIES OF DIABETIC NEPHROPATHY: A CASE REPORT
Formerly published in Volume 5, No. 8 (January–June 2020)
Abstract
This is a case of a 55 -year old man with type 2 diabetes mellitus with hypertension who defaulted clinical visits and was subsequently brought to the accident and emergency department with acute deterioration of kidney function. He had five sessions of haemodialysis with some episodes of intradialysis hypotension in the first three sessions. This case was selected for reporting in order to highlight four pertinent issues in the management of the diabetic patient with nephropathy which this patient manifested. These include onset of severe anaemia at relatively earlier stage of chronic kidney disease (CKD) compared to non-diabetic renal diseases and development of clinical features of uraemia at a lower level of serum creatinine compared to patients with non-diabetic renal disease. Other non-specific
characteristics include high risk of intra-dialytic hypotension and high risk of failure of arterio-venous fistula maturation.
Downloads
References
Vecihi B. Diabetic nephropathy. 2015; Available at (accessed on 19th June, 2015)http://emedicine.medscape.com/article/238946-overview
2. National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49:S12-S154.
3 US Renal Data System (USRDS). Annual data report: 2009. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda MD. 2009; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases,.
4. Alebiosu CO, Ayodele OE. The increasing prevalence of diabetic nephropathy as a cause of end stage renal disease in Nigeria. Trop Doctor. 2006;36:218-219.
5. Ulasi II, Ijoma CK. The Enormity of Chronic Kidney Disease in Nigeria: The Situation in a Teaching Hospital in SouthEast Nigeria. J Trop Med. 2010;2010.
6. Agaba EI, Agaba PA, Puepet FH. Prevalence of microalbuminuria in newly diagnosed type 2 diabetic patients in Jos Nigeria. Afr J MedMedSci.2004;33(1):19-22.
7. Hasslacher C, Ritz E, Wahl P, Michae C. Similar risks of nephropathy in patients with type I or type II diabetes mellitus. Nephrol Dial Trans. 1989;4:859-863.
8. Wolf G, Sharma K. Pathogenesis, clinical manifestations, and natural history of diabetic nephropathy. In: Johnson RJ, Feehaly J, J F, eds. Comprehensive clinical nephrology. 5th ed. Philadelphia: Elsevier saunders; 2015:354-371.
9. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med.1999;341:1127-1133.
10. Ritz E, Haxsen V. Diabetic nephropathy and anaemia. EurJ Clin Invest. Dec 2005;35 Suppl3:66-74.
11. Garabed E, Norbert L, Kai-Uwe E. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int. 2012;283-287.
12. Beynon G. The influence of the autonomic nervous sys tem in the control of erythropoietin secretion in the hypoxic rat. J Physiol. 1977;266(2):347-360.
13. Takaku F, Hirashima K, Okinaka S. Effect of thebilateral sectionofthe splanchnicnerveon erythropoiesis.Nature.91961;191:500-501.
14. Winkler AS, Marsden J, Chaudhuri KR, Hambley H, Watkins PJ. Erythropoietin depletion and anaemia in diabetes mellitus. Diabet Med. 1999; 16(10):813-819.
15. Biaggioni I, Robertson D, Krantz S, Jones M, Haile V. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin. Ann Intern Med. 1994;121(3):181-186.
16. Bosman DR, Winkler AS, Marsden JT, Macdougall IC, Watkins PJ. Anemia With Erythropoietin Deficiency Occurs Early in Diabetic Nephropathy. Diabet Care. 2001;24(3):495-499.
17. Calvo C, Maule S, Mecca F, QuadriR, Martina G, Cavallo P. The influence of autonomic neuropathy on hypotension during hemodialysis. ClinAutonRes.2002;12:84-87.
18. Zhong H, Liu F, Sha ZH, Tang XL, Qin M, Zhou XL, et al. Blood pressure variation of hypertensive diabetic nephropathy patients undergoing peritoneal dialysis. Sichuan Da XueXueBaoYiXueBan.2012;43(3):429-433.
19. Toth L, Voros P, Lengyel Z, Liptai M, Nemeth C, Kammerer L. Diurnal blood pressure variations in incipient and end stage diabetic renal disease. Diabetes Res ClinPract.2000;49(1):1-6.
20. Van Kuijk WH, Wirtz JJ, Grave W, de-Heer F, Menheer PP, van Hoof JP, et al, Vascular reactivity during combined ultrafiltrationhaemodialysis: influence of dialysate sodium. Nephrol Dial Transplant. 1996;11:323-328.21.
21. OliverMJ,EdwardsLJ,ChurchillDN.Impact of sodium and ultrafiltration profiling on hemodialysis-related symptoms. J Am Soc Nephrol. 2001; 12: 151-156.
22. Bakris GL. Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus. Mayo Clin Proc. 2011;86:444-456.
23. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelferb C, HandlerJ, et al. 2014 evidence-basedguideline forthe management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311: 507-520.
24. National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49:S12-S154.
